Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Increased circulating levels of matrix metalloproteinase-2 and-9 in women with the polycystic ovary syndrome

Tools
- Tools
+ Tools

Lewandowski, K. C., Komorowski, J., O'Callaghan, C. J., Tan, B. K., Chen, J., Prelevic, G. M. and Randeva, Harpal S.. (2006) Increased circulating levels of matrix metalloproteinase-2 and-9 in women with the polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism , Vol.91 (No.3). pp. 1173-1177. ISSN 0021-972X

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1210/jc.2005-0648

Abstract

Introduction: Matrix metalloproteinases (MMPs) have been implicated in various pathological processes including inflammatory response, cardiovascular disease, and recently also in ovarian dysfunction. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age and is characterized by chronic anovulation, insulin resistance, and increased prevalence of cardiovascular risk factors. Circulating levels of MMPs and their tissue inhibitors (TIMPs) so far have not been assessed in the PCOS. Materials and Methods: Serum levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 were measured in 23 women with PCOS [age (mean +/- SD), 30.5 +/- 6.7 yr; body mass index, 35.8 +/- 7.5 kg/m(2)] and 22 healthy, regularly menstruating women (age, 29.4 +/- 5.6; body mass index, 31.7 +/- 9.2 kg/m(2)). Results: Women with PCOS had significantly higher concentrations of MMP-2 (999.8 +/- 155 vs. 521.8 +/- 242 ng/ml; P < 0.001), MMP-9 (592.4 +/- 279 vs. 345 +/- 309; P = 0.007), and TIMP-1 levels (823.8 +/- 145 vs. 692 +/- 210 ng/ml; P = 0.02) than control healthy women. There was no difference in TIMP-2 levels (47.3 +/- 30 vs. 44.4 +/- 39.7 ng/ml; P = 0.21) between women with PCOS and controls. Conclusions: Obese women with PCOS have elevated serum concentrations of MMP-2 and -9. It might be hypothesized that elevated MMP concentrations may be related to increased cardiovascular risk in PCOS and/or menstrual irregularities associated with this syndrome.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Warwick Medical School
Journal or Publication Title: Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
ISSN: 0021-972X
Date: March 2006
Volume: Vol.91
Number: No.3
Number of Pages: 5
Page Range: pp. 1173-1177
Identification Number: 10.1210/jc.2005-0648
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access
URI: http://wrap.warwick.ac.uk/id/eprint/33795

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us